Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumours of the Uterus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00092482
What this trial is testing

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 3,882
Not applicableStudy completedNCT02209532
What this trial is testing

A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping

Who this might be right for
Endometrial CancerUterine CancerCervical Cancer
Novadaq Technologies ULC, now a part of Stryker 180
Post-approval studies (Phase 4)Ended earlyNCT04132349
What this trial is testing

Ulipristal Acetate in Symptomatic Uterine Fibroid

Who this might be right for
Uterine FibroidHeavy Menstrual Bleeding
Mỹ Đức Hospital 25
Early research (Phase 1)Looking for participantsNCT06476808
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

Who this might be right for
High-grade Serous Ovarian Carcinoma (HGSOC)Uterine Serous Carcinoma (USC)Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 240
Post-approval studies (Phase 4)Study completedNCT05426148
What this trial is testing

Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

Who this might be right for
Cervical Intraepithelial NeoplasiaCervical CancerVaginal Intraepithelial Neoplasia+2 more
Xiamen Innovax Biotech Co., Ltd 540
Not applicableStudy completedNCT02320578
What this trial is testing

2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial

Who this might be right for
Uterine Cervical NeoplasmsLaparoscopic Surgical Procedures
Catholic University of the Sacred Heart 26
Testing effectiveness (Phase 2)Looking for participantsNCT07454915
What this trial is testing

PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia

Who this might be right for
Cervical Intraepithelial Neoplasia Grade 2/3Human Papilloma Virus Infection Type 16
PapiVax Biotech, Inc. 138
Large-scale testing (Phase 3)Study completedNCT00156208
What this trial is testing

Safety of Treatment of Uterine Fibroids With Asoprisnil

Who this might be right for
Fibroid UterusLeiomyomaMenorrhagia+2 more
Abbott 166
Testing effectiveness (Phase 2)Study completedNCT03073525
What this trial is testing

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Who this might be right for
Advanced Gynecological CancersOvarian CancerCervical Cancer+1 more
Gradalis, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00156182
What this trial is testing

A Long-Term Safety Study of Asoprisnil in the Treatment of Uterine Fibroids.

Who this might be right for
Leiomyoma
Abbott 38
Not applicableStudy completedNCT03207074
What this trial is testing

Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?

Who this might be right for
Endometrial NeoplasmsEndometrial CancerEndometrial Hyperplasia+1 more
Imperial College London 150
Not applicableLooking for participantsNCT07810920
What this trial is testing

Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine

Who this might be right for
EndometriosisAdenomyosis of UterusLeiomyoma (Uterine Fibroids)+3 more
Semmelweis University 1,600
Not applicableEnded earlyNCT01234480
What this trial is testing

Intended Use Study of the BD SurePath Plus™ Pap

Who this might be right for
Uterine Cervical NeoplasmsUterine Cervical CancerNeoplasms, Squamous Cell+4 more
Becton, Dickinson and Company 5,859
Very early researchEnded earlyNCT04906382
What this trial is testing

Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer

Who this might be right for
Lynch SyndromeRecurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell Adenocarcinoma+4 more
Floor Backes, MD 2
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Testing effectiveness (Phase 2)UnknownNCT00199680
What this trial is testing

Interest of PET Imagery With 18-FDG in the Extension Assessment of the Cervical Cancer

Who this might be right for
Cervical Cancer
University Hospital, Limoges 42
Testing effectiveness (Phase 2)Looking for participantsNCT05797168
What this trial is testing

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Who this might be right for
Ovarian CancerLung AdenocarcinomaEndometrial Cancer+1 more
AstraZeneca 602
Not applicableLooking for participantsNCT07025213
What this trial is testing

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

Who this might be right for
Endometrial Cancer
National Institute of Cancerología 80
Not applicableEnrolling By InvitationNCT05524480
What this trial is testing

Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention

Who this might be right for
Cancer Prevention
The University of Texas Health Science Center, Houston 2,000
Testing effectiveness (Phase 2)Study completedNCT00027690
What this trial is testing

Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Recurrent Uterine Corpus Carcinoma
National Cancer Institute (NCI) 56
Next Page